Proportion of 
a = Any time point Prior to Treatment (PTT); D = Day; PoC = Post-challenge; PoI = Post-infusion; Term = Terminal* = Statistically significant difference between groups (p < 0.05, two-sided Fisher’s test)Only animals that received a full dose of ANTHRASIL or placebo and were bacteremic at least once prior to treatment were included for analysis (Modified Intent-To-Treat (MITT))At 1 h post-infusion, all toxin levels in the ANTHRASIL group were less than LOD, and the geometric mean toxin level in the IGIV group was significantly greater than LOD (p < 0.0001). From 12 h PoI through 3 days PoI and at the terminal measurement, geometric mean toxin levels in the IGIV group were significantly greater than those in the ANTHRASIL group (p < 0.0001) (